Top 5 Key Effects of Glucagon on Product Attributes
Published: July 19, 2026 16:34
Author: Luis Calhoun
Abstract: Glucagon’s key effects—glycogenolysis, gluconeogenesis, lipolysis, ketogenesis, and insulin secretion inhibition—directly shape peptide product attributes. In the current market, synthetic glucagon analogs (e.g., dasiglucagon) demonstrate superior stability (up to 12-month shelf life at room temperature) versus native peptides (2-8°C storage). Leading brands (Novo Nordisk, Zealand Pharma) hold FDA/EMA approvals, while generic manufacturers face purity challenges (>98% vs. 95% threshold). Market trends show 8.5% CAGR (2024-2030) driven by dual-action peptides (glucagon-GLP-1). Selection criteria prioritize lyophilized formulations for logistics and third-party HPLC purity certificates.